News Eylea vs Lucentis for Treatment-Naive Neovascular AMD by Medscape • 2015/10/05 • 0 Comments A new study compares outcomes between these two drugs in previously untreated patients with neovascular AMD. How do they stack up? BMC Ophthalmology Full Story →